{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:17:38Z","timestamp":1775852258682,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Myxomatous mitral valve disease (MMVD) is the most common diagnosed cardiovascular disease in dogs. Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) tests are used to diagnose congestive heart failure, but there are conflicting reports about their value in diagnosing the subclinical stages of MMVD in dogs. Moreover, the diagnostic value of blood lipoproteins in dogs with MMVD is still unclear. The purpose of this study was to assess the serum concentrations of ANP, BNP and lipoproteins of dogs with MMVD and to evaluate the correlation of the levels of ANP and BNP with lipoproteins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This study was performed on 24 dogs with MMVD and 10 healthy dogs. Dogs with MMVD were classified in to stages B1 (<jats:italic>n<\/jats:italic>\u2009=\u200911), B2 (<jats:italic>n<\/jats:italic>\u2009=\u20096), C (<jats:italic>n<\/jats:italic>\u2009=\u20094) and D (<jats:italic>n<\/jats:italic>\u2009=\u20093) groups according to the classification suggested by American College of Veterinary Internal Medicine guidelines. Our results showed that the mean serum BNP levels were significantly increased for all MMVD groups compared to control dogs. The mean serum ANP levels for the stage B2, C and D groups were significantly higher than the control group, while the mean serum ANP concentrations did not differ significantly between the stage B1 and control groups. An increase in BNP level was observed in 87.5% of patients. Although BNP concentrations were elevated in 100% of dogs with stages C, D and B2, high BNP was observed in 72.72% of dogs with stage B1. Regarding ANP, 58.33% of patients had an increase in ANP. However, elevated ANP levels were found in only 27.27% of patients in stage B1, while increased ANP levels were observed in 66.66 and 100% of patients in stage B2 and C\/D groups respectively. Also, in all patients with MMVD, the mean serum concentrations of high-density lipoprotein cholesterol (HDL-C) were approximately 1.7 to 2 times significantly lower than the control group. Additionally, the mean serum low-density lipoprotein cholesterol (LDL-C) increased significantly (1.9-2.7 times) compared to the control group.<\/jats:p>\n                <jats:p>There was a significant inverse correlation between HDL-C and BNP, and HDL-C and ANP. LDL-C showed a significant positive correlation with BNP, and ANP. Also, LDL-C, but not HDL-C, had a significant positive correlation with LA\/AO ratio, LVIDd, LVIDdN and VHS. BNP and ANP showed a significant positive correlation with LA\/AO, LVIDd, LVIDdN and VHS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Serum BNP has a greater diagnostic value than serum ANP in dogs with MMVD. In addition, serum BNP can be used to determine the subclinical stages of B1 and B2 MMVD. This study also suggests that dogs with subclinical MMVD, showed an increase in BNP along with a decrease in HDL-C and an increase in LDL-C, which are known to be risk factors for cardiovascular diseases in human. However, it seems that high LDL-C is more involved in the pathogenesis of MMVD than low HDL-C. Therefore, periodic testing of serum lipoproteins is recommended in high-risk patients, even if total cholesterol levels are normal.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-022-03548-2","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:02:46Z","timestamp":1671778966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Zohreh","family":"Khaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parviz","family":"Nooshirvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darioush","family":"Shirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Masoudifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"issue":"4","key":"3548_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.cvsm.2010.03.008","volume":"40","author":"M Borgarelli","year":"2010","unstructured":"Borgarelli M, Haggstrom J. Canine degenerative myxomatous mitral valve disease: natural history, clinical presentation and therapy. Vet Clin North Am Small Anim Pract. 2010;40(4):651\u201363.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"3","key":"3548_CR2","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","volume":"33","author":"BW Keene","year":"2019","unstructured":"Keene BW, Atkins CE, Bonagura JD, Fox PR, H\u00e4ggstr\u00f6m J, Fuentes VL, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33(3):1127\u201340.","journal-title":"J Vet Intern Med"},{"key":"3548_CR3","volume-title":"Text book of veterinary internal medicine","author":"SJ Ettinger","year":"2017","unstructured":"Ettinger SJ, Feldmen EC, Cote E. Text book of veterinary internal medicine. 8th ed. Missouri: Elsevier; 2017.","edition":"8"},{"issue":"3","key":"3548_CR4","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2460\/javma.256.3.340","volume":"256","author":"Y Hori","year":"2020","unstructured":"Hori Y, Iguchi M, Hirakawa A, Kamiya Z, Yamano S, Ibaragi T, et al. Evaluation of atrial natriuretic peptide and cardiac troponin I concentrations for assessment of disease severity in dogs with naturally occurring mitral valve disease. J Am Vet Med Assoc. 2020;256(3):340\u20138.","journal-title":"J Am Vet Med Assoc"},{"key":"3548_CR5","unstructured":"Kaunda RE. Cardiovascular physiology concepts. 2021; 3th edition, published by Wolters Kluwer, USA. ISBN-13: 9781975150075 ."},{"key":"3548_CR6","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"K Kuwahara","year":"2021","unstructured":"Kuwahara K. The natriuretic peptide system in heart failure: diagnostic and therapeutic implications. Pharmacol Ther. 2021;227:107863.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3548_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1024\/0301-1526.35.4.215","volume":"35","author":"G Lupatelli","year":"2006","unstructured":"Lupatelli G, Marchesi S, Siepi D, Bagaglia F, Palumbo B, Roscini AR, et al. Natriuretic peptides levels are related to HDL-cholesterol with no influence on endothelium, dependent vasodilation. Vasa. 2006;35(4):215\u201320.","journal-title":"Vasa"},{"key":"3548_CR8","doi-asserted-by":"crossref","unstructured":"Seage EC, Drobatz KJ, Hess RS. Spectrophotometry and ultracentrifugation for measurement of plasma lipids in dogs with dabetes mellitus. J Vet Intern Med. 2018;1-6.","DOI":"10.1111\/jvim.14880"},{"issue":"10","key":"3548_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/jsap.12396","volume":"56","author":"PG Xenoulis","year":"2015","unstructured":"Xenoulis PG, Steiner JM. Canine hyperlipidaemia. J Small Anim Pract. 2015;56(10):595\u2013605.","journal-title":"J Small Anim Pract"},{"key":"3548_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1748-5827.2000.tb03173.x","volume":"41","author":"T Falk","year":"2000","unstructured":"Falk T, J\u00f6nsson L. Ischemic heart disease in the dog. J Small Anim Pract. 2000;41:97\u2013103.","journal-title":"J Small Anim Pract"},{"key":"3548_CR11","volume-title":"Tietz fundamentals of clinical chemistry and molecular diagnostics","author":"CA Burtis","year":"2015","unstructured":"Burtis CA, Bruns DE. Tietz fundamentals of clinical chemistry and molecular diagnostics. 7th ed. Missouri: Elsevier; 2015.","edition":"7"},{"issue":"3","key":"3548_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0009-8981(85)90091-9","volume":"151","author":"PW Wilson","year":"1985","unstructured":"Wilson PW, Zech LA, Gregg RE, Shaefer EJ, Hoeg JM, Sprecher DL, et al. Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta. 1985;151(3):285\u201391.","journal-title":"Clin Chim Acta"},{"key":"3548_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"issue":"4","key":"3548_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cvsm.2010.03.004","volume":"40","author":"MA Oyama","year":"2010","unstructured":"Oyama MA, Singletary GE. The use of NT-proBNP assay in the management of canine patients with heart disease. Vet Clin North Am Small Anim Pract. 2010;40(4):545\u201358.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"3548_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1292\/jvms.71.925","volume":"71","author":"N Takemura","year":"2009","unstructured":"Takemura N, Toda N, Miyagawa Y, Asano K, Tejima K, Kanno N, et al. Evaluation of plasma Nterminal pro-brain natriuretic peptide (NT-proBNP) concentrations in dogs with mitral valve insufficiency. J Vet Med Sci. 2009;71:925\u20139.","journal-title":"J Vet Med Sci"},{"issue":"5","key":"3548_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1292\/jvms.61.523","volume":"61","author":"K Asano","year":"1999","unstructured":"Asano K, Masuda K, Okumura M, Kadosawa T, Fujinaga T. Plasma atrial and brain natriuretic peptide levels in dogs with heart failure. J Vet Med Sci. 1999;61(5):523\u20139.","journal-title":"J Vet Med Sci"},{"issue":"1","key":"3548_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1760-2734(06)70002-9","volume":"2","author":"J H\u00e4ggstr\u00f6m","year":"2000","unstructured":"H\u00e4ggstr\u00f6m J, Hansson K, Kvart C, Pedersen HD, Vuolteenaho O, Olsson K. Relationship between different natriuretic peptides and severity of naturally acquired mitral regurgitation in dogs with chronic myxomatous valve disease. J Vet Cardiol. 2000;2(1):7\u201316.","journal-title":"J Vet Cardiol"},{"issue":"2","key":"3548_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1939-1676.2003.tb02430.x","volume":"17","author":"KA MacDonald","year":"2003","unstructured":"MacDonald KA, Kittleson MD, Munro C, Kass P. Brain natriuretic peptide concentration in dogs with heart disease and congestive heart failure. J Vet Intern Med. 2003;17(2):172\u20137.","journal-title":"J Vet Intern Med"},{"key":"3548_CR19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2460\/javma.239.8.1077","volume":"239","author":"Y Hori","year":"2011","unstructured":"Hori Y, Yamano S, Kanai K, Hoshi F, Itoh N, Higuchi S-I. Clinical implications of measurement of plasma atrial natriuretic peptide concentration in dogs with spontaneous heart disease. J Am Vet Med Assoc. 2011;239:1077\u201383.","journal-title":"J Am Vet Med Assoc"},{"issue":"4","key":"3548_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1292\/jvms.20-0629","volume":"83","author":"M Ogawa","year":"2021","unstructured":"Ogawa M, Hori Y, Kanno N, Iwasa N, Toyofuku T, Isayama N, et al. Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease. J Vet Med Sci. 2021;83(4):705\u201315.","journal-title":"J Vet Med Sci"},{"issue":"10","key":"3548_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2460\/javma.232.10.1496","volume":"232","author":"MA Oyama","year":"2008","unstructured":"Oyama MA, Fox PR, Rush JE, Rozanski EA, Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. J Am Vet Med Assoc. 2008;232(10):1496\u2013503.","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"3548_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ani12020209","volume":"12","author":"M Bagardi","year":"2022","unstructured":"Bagardi M, Zamboni V, Locatelli C, Galizzi A, Ghilardi S, Brambilla PG. Management of Chronic Congestive Heart Failure Caused by Myxomatous mitral valve disease in dogs: a narrative review from 1970 to 2020. Animals (Basel). 2022;12(2):209.","journal-title":"Animals (Basel)"},{"issue":"1","key":"3548_CR23","first-page":"107","volume":"142","author":"K Hasegawa","year":"1993","unstructured":"Hasegawa K, Fujiwara H, Doyama K, Mukoyama M, Nakao K, Fujiwara T, et al. Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am J Pathol. 1993;142(1):107\u201316.","journal-title":"Am J Pathol"},{"issue":"11","key":"3548_CR24","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1515\/CCLM.2008.295","volume":"46","author":"J Mair","year":"2008","unstructured":"Mair J. Biochemistry of B-type natriuretic peptide--where are we now? Clin Chem Lab Med. 2008;46(11):1507\u201314.","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"3548_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jacc.2019.07.037","volume":"74","author":"F Emanuelsson","year":"2019","unstructured":"Emanuelsson F, Nordestgaard BG, Tybj\u00e6rg-Hansen A, Benn M. Impact of LDL cholesterol on microvascular versus macrovascular disease: a Mendelian randomization study. J Am Coll Cardiol. 2019;74(11):1465\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3548_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/biomedicines9040418","volume":"9","author":"G Cismaru","year":"2021","unstructured":"Cismaru G, Serban T, Tripe A. Ultrasound methods in the evaluation of atherosclerosis: from pathophysiology to clinic. Biomedicines. 2021;9(4):418.","journal-title":"Biomedicines"},{"issue":"1","key":"3548_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCRESAHA.114.300935","volume":"114","author":"TF Luscher","year":"2014","unstructured":"Luscher TF, Landmesser U, von Echardstein A, Fogelman AM. High-density lipoprotein. Circ Res. 2014;114(1):171\u201382.","journal-title":"Circ Res"},{"key":"3548_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0021-9150(99)00186-0","volume":"147","author":"JO Toikka","year":"1999","unstructured":"Toikka JO, Ahotupa M, Viikari JS, Niinikoski H, Taskinen M, Irjala K, et al. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis. 1999;147:133\u20138.","journal-title":"Atherosclerosis"},{"key":"3548_CR29","first-page":"44","volume":"105","author":"DM Stafforini","year":"1992","unstructured":"Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. Trans Assoc Am Phys. 1992;105:44\u201363.","journal-title":"Trans Assoc Am Phys"},{"issue":"Suppl. 1: s3-10","key":"3548_CR30","doi-asserted-by":"publisher","first-page":"s27","DOI":"10.5604\/01.3001.0010.5495","volume":"16","author":"HH Wang","year":"2017","unstructured":"Wang HH, Garruti G, Liu M, Portincasa P, Wang DQ. Cholesterol and lipoprotein metabolism and atherosclerosis: recent advances in reverse cholesterol transport. Ann Hepatol. 2017;16(Suppl. 1: s3-105):s27\u201342.","journal-title":"Ann Hepatol"},{"issue":"2","key":"3548_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2004.02.025","volume":"120","author":"RP Gallegos","year":"2004","unstructured":"Gallegos RP, Swingen C, Xu XJ, Wang X, Bianco R, Jerosch-Herold M, et al. Infarct extent by MRI correlates with peak serum troponin level in the canine model. J Surg Res. 2004;120(2):266\u201371.","journal-title":"J Surg Res"},{"issue":"3","key":"3548_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0021-9975(05)80126-4","volume":"118","author":"Y Kagawa","year":"1998","unstructured":"Kagawa Y, Hirayama K, Uchida E, Izumisawa Y, Yamaguchi M, Kotani T, et al. Systemic atherosclerosis in dogs: histopathological and immunohistochemical studies of atherosclerotic lesions. J Comp Pathol. 1998;118(3):195\u2013206.","journal-title":"J Comp Pathol"},{"key":"3548_CR33","first-page":"1","volume":"Suppl 38","author":"L J\u00f6nsson","year":"1972","unstructured":"J\u00f6nsson L. Coronary arterial lesions and myocardial infarcts in the dog: a pathologic and microangiographic study. Acta Vet Scand. 1972;Suppl 38:1\u201380.","journal-title":"Acta Vet Scand"},{"key":"3548_CR34","doi-asserted-by":"crossref","unstructured":"Falk T, J\u00f6nsson L, Olsen LH, Pedersen HD. Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease. Cardiovasc Pathol. 2006;15(4):185\u201393.","DOI":"10.1016\/j.carpath.2006.04.003"},{"key":"3548_CR35","doi-asserted-by":"crossref","unstructured":"Takeuchi H, Sata M. The relationship among brain natriuretic peptide (BNP), cholesterol and lipoprotein. Heart Asia. 2012;4(1):11\u20135.","DOI":"10.1136\/heartasia-2011-010042"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-022-03548-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-022-03548-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:06:52Z","timestamp":1671779212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-022-03548-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3548"],"URL":"https:\/\/doi.org\/10.1186\/s12917-022-03548-2","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"27 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All phases of this study were approved by the Animal Ethics Guidelines of the Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran (No: 7508017.6.24). All methods are reported in accordance with Arrive guidelines () for the reporting of animal experiments. Written informed consent was obtained from the dog owners for their dogs to be used in this study. This study was conducted in accordance with the Animal Ethical Guidelines of the Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran (No: 7508017.6.24).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors approved the final manuscript and they have no competing intrests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}